Merge Therapeutics is a pioneering biotech company developing multispecific antibodies designed to fundamentally shift the treatment paradigm for autoimmune diseases
Merge Therapeutics is a pioneering biotech company developing multispecific antibodies designed to fundamentally shift the treatment paradigm for autoimmune diseases. Their goal is to create therapies that can reprogram immune responses and provide lasting remission for patients.